• Home  HOME
  • About  ABOUT US
  • About  PRODUCTS
  • Research  RESEARCH
  • Investors  INVESTOR RELATIONS
  • Contact  CONTACT
  • AFFILIATED WEBSITES
  • Contact
  •  ABOUT US
  • History
  •  PRODUCTS
  • USA
  • Canada
  • Israel
  • International
  •  INVESTOR RELATIONS
  • Investor Relations
  • Financials
  • Annual Reports
  • Fundamentals
  • Earnings & Proxy Reports
  • News Releases
  • Investor FAQ
  • E-mail Alerts
  • Contact Information
  • Safe Harbor
  • AFFILIATED WEBSITES
  • Taro Pharmaceutical Industries Ltd. Taro U.S.A
  • Taro Canada Taro Canada
  • Taro Israel Taro Israel
  • Taro International Taro International
  • Sun Pharmaceutical Ind. Ltd
  • Sun Pharmaceutical USA
  • Chattem Chemicals Inc.
Skip to main content

Taro Pharmaceutical Industries

  • WORLDWIDE SITES
      • USA
      • Canada
      • Israel
      • International
Text Size A A A

Taro-Zoledronic Acid, Injectable

Print Home » Taro-Zoledronic Acid, Injectable
Submitted by tarocms on Mon, 06/18/2012 - 07:46
Upload Pdf: 
PDF icon ZOLEDRONIC 5mg-100 mL PM-16Oct14 FR.pdf
Principes actifs: 
l’acide zolédronique
CUP: 
063691074439
DIN: 
02415100
Format: 
100mL
Qte/caisses: 
1
Listes de Medicaments: 
À venir
Strength: 
5 mg/100 mL
Product Type: 
RX
Original: 
Aclasta®

Category:

  • Régulateur du métabolisme des lipides
  • Log in or register to post comments

Copyright © Taro Pharmaceutical Industries Ltd.  

Privacy Statement |  Terms of Use
Sitemap |  Site Credits